• Sunday, May 31, 2020
  • Last Update : 03:09 pm

WHO: 20 Covid-19 vaccines in development as world races for cure

  • Published at 08:09 pm March 21st, 2020
US-clinical-trial-for-coronavirus-vaccine-to-begin-Monday
File photo: Employee Philipp Hoffmann, of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12, 2020 Reuters

'The vaccines are still a long way away from being available for public use'

The World Health Organization (WHO) is working with scientists across the globe on at least 20 different coronavirus vaccines with some already in clinical trials in record time — just 60 days after sequencing the gene, reports CNBC.

“The acceleration of this process is really truly dramatic in terms of what we’re able to do, building on work that started with SARS, that started with MERS and now is being used for Covid-19,” Dr Maria Van Kerkhove, the technical lead for WHO’s emergencies program, said at a press conference at the organization’s headquarters in Geneva on Friday.

The vaccines are still a long way away from being available for public use, WHO officials cautioned. Leading scientists say the clinical trials and safety approvals needed to get a workable vaccine to market could take up to 18 months.

Dr Mike Ryan, executive director of WHO’s emergencies program, said the trials are necessary. There’s only one thing more dangerous than a bad virus “and that’s a bad vaccine,” he said.

“We have to be very, very, very careful in developing any product that we’re going to inject into potentially most of the world’s population,” Ryan said, adding that the first human trials on a vaccine that started this week in the US were “unprecedented in speed.” He said that would have never happened if China and other countries hadn’t shared the genetic sequence of Covid-19 with the rest of the world.

The National Institutes of Health has been fast-tracking work with biotech company Moderna to develop a vaccine using the genetic sequence of the new coronavirus. The trial started on Monday at the Kaiser Permanente Washington Health Research Institute in Seattle, Washington.

The early-stage, or phase 1, trial will test the vaccine on 45 males and non-pregnant females between the ages of 18 and 55, according to trial details on NIH’s website.

Once a vaccine is found, WHO officials warned about other logistical, financial and ethical hurdles world leaders will face.

“Even if we get a vaccine that’s effective, we have to have that vaccine that’s available for everybody. There has to be fair and equitable access to that vaccine for everybody,” Ryan said, adding the world won’t be protected from the coronavirus unless everybody is vaccinated.

58
57
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail